Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.
- Submitting institution
-
Institute of Cancer Research: Royal Cancer Hospital (The)
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 186
- Type
- D - Journal article
- DOI
-
10.1056/NEJMoa1911206
- Title of journal
- N Engl J Med
- Article number
- -
- First page
- 2506
- Volume
- 381
- Issue
- 26
- ISSN
- 1533-4406
- Open access status
- Not compliant
- Month of publication
- December
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
https://www.nejm.org/doi/10.1056/NEJMoa1911206
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
19
- Research group(s)
-
-
- Citation count
- 89
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- a) The author made a substantial contribution to the conception and design of the study; the organisation of the conduct of the study; carrying out the study; analysis and interpretation of study data.
b) The author helped draft the output
- Non-English
- No
- English abstract
- -